Compare HLNE & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLNE | NVST |
|---|---|---|
| Founded | 1991 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.6B |
| IPO Year | 2017 | 2019 |
| Metric | HLNE | NVST |
|---|---|---|
| Price | $102.77 | $26.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $156.78 | $26.46 |
| AVG Volume (30 Days) | 623.7K | ★ 2.8M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | 41.64 | ★ 104.31 |
| EPS | ★ 3.98 | 0.56 |
| Revenue | $758,993,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | $9.69 | $6.67 |
| Revenue Next Year | $15.81 | $3.55 |
| P/E Ratio | ★ $27.34 | $48.46 |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $71.88 | $18.77 |
| 52 Week High | $155.66 | $30.42 |
| Indicator | HLNE | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 43.48 |
| Support Level | $98.37 | $26.68 |
| Resistance Level | $106.17 | $27.00 |
| Average True Range (ATR) | 3.59 | 0.79 |
| MACD | -0.56 | -0.15 |
| Stochastic Oscillator | 39.59 | 3.23 |
Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.